A testament to sustained macrolide efficacy

被引：6

作者：

Bishai, W ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21231 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2003年 / 36卷 / 07期

关键词：

D O I：

10.1086/368208

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：935 / 936

页数：2

共 6 条

[1] PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA [J].

AUSTRIAN, R ;

GOLD, J .

ANNALS OF INTERNAL MEDICINE, 1964, 60 (05) :759-+

[2] The in vivo-in vitro paradox in pneumococcal respiratory tract infections [J].

Bishai, W .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (03) :433-436

[3] Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia [J].

Gleason, PP ;

Meehan, TP ;

Fine, JM ;

Galusha, DH ;

Fine, MJ .

ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (21) :2562-2572

[4] Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae [J].

Lonks, JR ;

Garau, J ;

Gomez, L ;

Xercavins, M ;

de Echagüen, AO ;

Gareen, IF ;

Reiss, PT ;

Medeiros, AA .

CLINICAL INFECTIOUS DISEASES, 2002, 35 (05) :556-564

[5] Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers [J].

Rodvold, KA ;

Gotfried, MH ;

Danziger, LH ;

Servi, RJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) :1399-1402

[6]

Rubin B K, 2000, Curr Opin Investig Drugs, V1, P169

← 1 →